Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-23-001601

Chief Operating Officer gave up 10,553 shares (to pay taxes)

  • Chief Operating Officer acquired 18,850 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BILINSKY IGOR Chief Operating Officer 2023-01-03 Option exercise +18,850 28,354 D: show line 1 in the form
BILINSKY IGOR Chief Operating Officer 2023-01-03 Shares withheld for taxes −10,553 $6.11 $64,479 17,801 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
BILINSKY IGOR Chief Operating Officer 2023-01-03 Option exercise · Restricted Stock Units −18,850 0 D: show line 3 in the form
Loading xslF345X03/tm232380d2_4seq1.xml…